Results 31 to 40 of about 31,824 (246)
Mapping the experiences of people with achalasia from initial symptoms to long‐term management
Background Achalasia is a rare motility disorder affecting the oesophagus, which is associated with a range of symptoms and different treatment strategies. Currently, little is known about people's experiences with achalasia and its management.
Melika Kalantari +3 more
doaj +1 more source
Background/Aims: Although an association between achalasia and esophageal cancer has been reported, whether achalasia confers a substantial increase in mortality is unknown.
Ga Hee Kim +18 more
doaj +1 more source
Wound healing of laparoscopic Heller's myotomy with and without an added dor's fundoplication, in pigs [PDF]
BACKGROUND: It has been argued that a Dor's fundoplication following myotomy is useful to prevent leakage due to overlooked iatrogenic perforations of esophagus and it is able to stop sphincter reconstruction, avoiding recurrent achalasia. Another strain
Azevedo, João Luiz Moreira Coutinho +5 more
core +3 more sources
EFFICACY OF PNEUMATIC DILATATION FOR THE TREATMENT OF IDIOPATIC ACHALASIA: A SINGLE-CENTRE EXPERIENCE [PDF]
Pneumatic dilatation (PD) and surgical miotomy (SM) are presentely the best treastments for untreated achalasia, with similar efficacy. There is no information on the relative efficacy of PD in younger compared to older patients.
Amvrosiadis, G +11 more
core +1 more source
High-resolution manometry, Chicago Classification v4.0, the functional lumen imaging probe, Panometry, and per-oral endoscopic myotomy (POEM) are all now integral parts of the landscape for managing achalasia or, more precisely, achalasia-like syndromes.
Peter J. Kahrilas +2 more
doaj +1 more source
Lymphocytic Esophagitis in Nonachalasia Primary Esophageal Motility Disorders: Improved Criteria, Prevalence, Strength of Association, and Natural History. [PDF]
Lymphocytic esophagitis (LE) is a histologic pattern with no established clinical correlates in the majority of patients. The goal of this study was to evaluate the association between nonachalasia primary esophageal motility disorders (PEMD) and LE ...
Brickley, Elizabeth B +8 more
core +1 more source
The precise pathogenesis of achalasia is still unclear. Neurodegenerative and/or demyelinating disorders (NDD) appear to share some common pathophysiological pathways described in achalasia such as inflammation, autoimmune, mitochondrial dysfunction, and
Khoury Salim T., Mari Amir
doaj +1 more source
Autonomic Nervous System Dysfunction in Achalasia
Background/Aims: Achalasia is an esophageal motility disorder characterized by dysphagia and noncardiac chest pain. Impairment of vagal function has been reported in achalasia.
Min-Jae Kim +3 more
doaj +1 more source
ACHALASIA TREATMENT IMPROVES SPECIFIC SYMPTOMS AND QUALITY OF LIFE: VALIDATION OF AN ACHALASIA SPECIFIC QUALITY OF LIFE QUESTIONNAIRE [PDF]
Background and aim: Therapies for achalasia aim to patients’ symptom relief, but they affect patient’s quality of life (QoL), too. An ad hoc question- naire evaluating both achalasia-related symptoms and disease related QoL is lacking. Aim: To validate a
A. Santonicola +6 more
core +1 more source
Esophageal Pharmacobezoar in a Patient with Achalasia: A Case Report
A few cases with esophageal bezoar have been reported in achalasia. We describe here a rare case of esophageal pharmacobezoar after ingestion of ferrous sulfate capsules in a patient with achalasia.
Hamid Tavakkoli
doaj +1 more source

